Global pharmaceutical company Merz Pharma is constructing a new production plant to produce dermal fillers at its site in Dessau, Germany.
Dr Euan Mackinnon explores if we can achieve surgical outcomes using a non-surgical approach
Aesthetic training provider Cosmetic Courses now provides an OFQUAL accredited Level 7 qualification in injectable treatments.
Aesthetic distributor Merz has launched a dermal filler containing a combination of hyaluronic acid and glycerol called Belotero Revive.
Global pharmaceutical company Merz Aesthetics has partnered with actress Gwyneth Paltrow for the company’s first global campaign of its botulinum toxin type A product Xeomin.
Medical device manufacturer Prollenium Medical Technologies has announced that its non-animal cross-linked hyaluronic acid dermal filler Revanesse Ultra has been approved by the US Food and Drug Administration (FDA).
Canadian dermal filler range Revanesse has released new training dates.
Global pharmaceutical company Merz will divide into three independently operating businesses: Merz Aesthetics, Therapeutics and Consumer Care.
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Aesthetic practitioner and founder of VIVA Skin Clinics, Dr Rupert Critchley, has launched a new training scheme for aesthetic injectors.